EUVIMEDEUVIMED entdecken
LeitlinieOpen Access

Nocturnal Stage 1 Hypertension Defined by 2025 Guidelines in Adults With Chronic Kidney Disease

Ting Zhang, Zhengping Zhou, Qiong Li, Xiaoyu Cai, Lin Lin, Hui Peng, Man Li, Cheng Wang, Xinying Jiang

JAMA Network Open · 14.01.2026 · 9 (1) · e2554035

DOI: 10.1001/jamanetworkopen.2025.54035 ↗

Kurz gefasst

Leitlinie in der Zeitschrift JAMA Network Open, online erschienen am 14.01.2026. Verfasst von Ting Zhang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology, Department of Medicine, the Fifth Affiliated Hospital Sun Yat-sen University, Zhuhai, Guangdong, China. Hauptthemen laut MEDLINE: Hypertension, Renal Insufficiency, Chronic. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance The 2025 American College of Cardiology/American Heart Association (ACC/AHA) blood pressure (BP) guideline introduced new hypertension criteria. However, the association between newly defined nocturnal stage 1 hypertension (nocturnal BP 110-120/65-70 mm Hg) and kidney function progression in the population not receiving dialysis with chronic kidney disease (CKD) in China remains unclear.

Objective

To determine whether nocturnal stage 1 hypertension as defined by 2025 ACC/AHA guidelines in patients with CKD is associated with kidney function progression. Design, Setting, and Participants A retrospective cohort study involving patients with CKD not receiving dialysis was conducted in China at the Third Affiliated Hospital of Sun Yat-sen University from August 2010 to December 2017 and at the Fifth Affiliated Hospital of Sun Yat-sen University from November 2017 to December 2024. Exposure Participants were categorized into 3 groups based on nocturnal BP measurements according to the 2025 ACC/AHA guidelines: nonhypertension (nocturnal BP <110/65 mm Hg), stage 1 hypertension (nocturnal BP 110-120/65-70 mm Hg), and stage 2 hypertension (nocturnal BP ≥120/70 mm Hg). Main Outcomes and Measures The primary outcome was a composite of kidney failure requiring replacement therapy (KFRT) and worsening kidney function (WKF). Secondary outcomes included the individual components of the primary outcome. Cox regression models were employed to assess the association between nocturnal stage 1 hypertension and outcomes.

Results

Among 2418 participants with CKD stage 1 through 4 not receiving dialysis included in the study, 1412 (58.4%) were men, the mean (SD) age was 45.4 (14.4) years, 436 (18.0%) had nocturnal nonhypertension, 345 (14.3%) had nocturnal stage 1 hypertension, and 1637 (67.7%) had nocturnal stage 2 hypertension. Over a median (IQR) follow-up of 3.9 (1.5-4.7) years, 394 composite kidney outcomes, 203 cases of KFRT, and 235 instances of WKF were recorded. After adjusting for confounders, nocturnal stage 1 hypertension (compared with nocturnal nonhypertension) was independently associated with an increased risk of KFRT (hazard ratio [HR], 2.37; 95% CI, 1.17-4.82), WKF (HR, 3.79; 95% CI, 1.04-13.84), and the composite kidney outcome (HR, 2.49; 95% CI, 1.31-4.72). In the older population (aged ≥65 years), nocturnal BP less than 110/65 mm Hg was associated with a higher risk of WKF and the composite kidney outcome compared with nocturnal BP in the range of 110/65 to 120/70 mm Hg. Conclusions and Relevance In this cohort study of adults with CKD not receiving dialysis, nocturnal stage 1 hypertension as defined by the 2025 ACC/AHA guidelines was independently associated with an increased risk of CKD progression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HypertensionRenal Insufficiency, ChronicHumansMaleRetrospective StudiesFemaleMiddle AgedDisease ProgressionPractice Guidelines as TopicChinaBlood PressureAgedAdult

Autor:innen und Institutionen

  • Division of Nephrology, Department of Medicine, the Fifth Affiliated Hospital Sun Yat-sen University, Zhuhai, Guangdong, China.
  • Guangdong Provincial Engineering Research Center of Molecular Imaging, the Fifth Affiliated Hospital Sun Yat-sen University, Zhuhai, Guangdong, China.
  • Division of Nephrology, Department of Medicine, the Third Affiliated Hospital Sun Yat-sen University, Guangzhou, Guangdong, China.

Zitieren

APA

Zhang, T., Zhou, Z., Li, Q., Cai, X., Lin, L., Peng, H., Li, M., Wang, C., & Jiang, X. (2026). Nocturnal Stage 1 Hypertension Defined by 2025 Guidelines in Adults With Chronic Kidney Disease. JAMA Network Open, 9(1), e2554035. https://doi.org/10.1001/jamanetworkopen.2025.54035

Vancouver

Zhang T, Zhou Z, Li Q, Cai X, Lin L, Peng H, et al. Nocturnal Stage 1 Hypertension Defined by 2025 Guidelines in Adults With Chronic Kidney Disease. JAMA Network Open. 2026;9(1):e2554035. doi:10.1001/jamanetworkopen.2025.54035

BibTeX
@article{Zhang2026,
  author = {Zhang, Ting and Zhou, Zhengping and Li, Qiong and Cai, Xiaoyu and Lin, Lin and Peng, Hui and Li, Man and Wang, Cheng and Jiang, Xinying},
  title = {Nocturnal Stage 1 Hypertension Defined by 2025 Guidelines in Adults With Chronic Kidney Disease},
  journal = {JAMA Network Open},
  year = {2026},
  volume = {9},
  number = {1},
  pages = {e2554035},
  doi = {10.1001/jamanetworkopen.2025.54035}
}
Kostenlos starten →